New agents for the treatment of infarcted myocardium

Local delivery of angiogenic growth factors for the treatment of myocardial ischemia has been well documented in various animal models, and clinical trials are now in progress. Our strategy was radically different, based on selective protection of some of the growth factors naturally present within...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The FASEB journal 2000-11, Vol.14 (14), p.2133-2134
Hauptverfasser:	Yamauchi, Hidetoshi, Desgranges, Pascal, Lecerf, Laure, Papy, Dulce, Tournaire, Marie‐Claude, Moczar, Madeleine, Loisance, Daniel, Barritault, Denis
Format:	Artikel
Sprache:	eng
Schlagworte:	Actins - analysis Animals Dextrans - therapeutic use Disease Models, Animal Endothelium, Vascular - cytology Endothelium, Vascular - drug effects heart Heart - drug effects Heart - physiopathology heparan sulfate mimetic Immunohistochemistry ischemia Muscle, Smooth - chemistry Myocardial Infarction - prevention & control Myocardium - chemistry Myocardium - pathology RGTA Swine von Willebrand Factor - analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!